Skip to main content
. 2017 Dec 20;9(4):4707–4721. doi: 10.18632/oncotarget.23523

Table 2. Correlation between SMOC1 methylation and the clinicopathological features of invasive colorectal tumors.

SMOC1 methylation
<36% (n = 235) ≥36% (n = 139) P
Age (y, mean ± SD) 66.3 ± 12.2 70.6 ± 10.6 <0.001
Gender
 Female 84 64 NS
 Male 151 75
Location
 Proximal 86 71 0.006
 Distal 149 68
Morphology
 Type 0 44 18 NS
 Depressed 30 8
 Flat 7 7
 Flat plus protruding 0 0
 Protruding 7 3
 Type 1 21 17
 Type 2 151 102
 Type 3 10 2
 Type 4 0 0
 Type 5 9 0
BRAF
 Mut 19 4 NS
 WT 216 135
KRAS
 Mut 48 72 <0.001
 WT 187 67
TP53
 Mut 56 31 NS
 WT 179 108
CIMP status
 Negative 200 88 <0.001
 Low 24 38
 High 11 13
MLH1 methylation
 Methylated 13 2 NS
 Unmethylated 222 137
pT category
 pT1 33 14 NS
 pT2 32 28
 pT3 125 81
 pT4 25 9
 NA 20 7
pN category
 pN0 140 83 NS
 pN1 47 35
 pN2 22 13
 NA 26 8
pM category
 pM0 184 120 NS
 pM1 31 15
 NA 20 4
Lymphatic invasion
 Negative 59 40 NS
 Positive 140 85
 NA 36 14
Vascular invasion
 Negative 85 58 NS
 Positive 113 67
 NA 37 14

NS, not significant; Mut, mutated; WT, wild type; NA, not available.